GlobeNewswire
-
Nordic Naturals Champions Ocean Conservation at 42nd Annual California Coastal Cleanup
23/09/2026 -
CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
23/09/2026 -
CROSSJECT et la BARDA consolident le plan de développement pédiatrique de ZEPIZURE® selon les attentes de la FDA avec un financement renforcé jusqu’en 2030
23/09/2026 -
Clareo Plastic Surgery Recognized as Best Plastic Surgeon in Boston
23/09/2026 -
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026 -
TwitchView® Quantitative Neuromuscular Monitoring Now Standardized Across Two Additional Midwest Academic Health Systems
23/09/2026 -
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026 -
New model-based analysis further supports the potential of TECVAYLI®▼ (teclistamab) plus daratumumab to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
23/09/2026 -
NexLife Includes a Licensed Doctor, a Nutrition Plan and Health Check-Ins After Treatment Starts in Every Compounded GLP-1 Subscription
23/09/2026 -
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
23/09/2026 -
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
23/09/2026 -
Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations
23/09/2026 -
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
23/09/2026 -
Cannabix’s BreathLogix Alcohol Screening Solution Enters U.S. Manufacturing Workplace Market with Deployment at Alabama Facility
23/09/2026 -
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
23/09/2026 -
SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
23/09/2026 -
Parexel Transforms Functional Service Provider (FSP) Model to Improve R&D Productivity and Enhance Post-Approval Product Lifecycle Services for Biopharmaceutical Companies
23/09/2026 -
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
23/09/2026 -
Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
23/09/2026
Pages